3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
Specimen Handling
15
Biopsy
14
fludarabine
12
Cytarabine
11
Cyclophosphamide
11
fludarabine phosphate
10
X-Rays
9
Whole-Body Irradiation
9
venetoclax
8
Magnetic Resonance Spectroscopy
8
Injections
8
asciminib
7
Azacitidine
7
Nuclear Medicine Department, Hospital
6
Mycophenolic Acid
6
Busulfan
6
decitabine and cedazuridine drug combination
5
Tacrolimus
5
Phantoms, Imaging
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Cyclosporine
5
CPX-351
5
ruxolitinib
4
ivosidenib
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Idarubicin
4
Decitabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
posaconazole
×
Myeloid
×
30 days
×
Clear all
NCT07155226
2026-05-19
MOMENTUM
AstraZeneca
Phase 1/2
Recruiting
84 enrolled